227 related articles for article (PubMed ID: 6244768)
1. Calcium and phosphate metabolism in tumoral calcinosis.
Mitnick PD; Goldfarb S; Slatopolsky E; Lemann J; Gray RW; Agus ZS
Ann Intern Med; 1980 Apr; 92(4):482-7. PubMed ID: 6244768
[TBL] [Abstract][Full Text] [Related]
2. Direct comparison of sustained infusion of human parathyroid hormone-related protein-(1-36) [hPTHrP-(1-36)] versus hPTH-(1-34) on serum calcium, plasma 1,25-dihydroxyvitamin D concentrations, and fractional calcium excretion in healthy human volunteers.
Horwitz MJ; Tedesco MB; Sereika SM; Hollis BW; Garcia-Ocaña A; Stewart AF
J Clin Endocrinol Metab; 2003 Apr; 88(4):1603-9. PubMed ID: 12679445
[TBL] [Abstract][Full Text] [Related]
3. Renal-resistant hormonoplethoric hypoparathyroidism with evidence for a defective response to cAMP.
Duck SC; Rosenberg EM; Ratzan SK; Haymond MW
J Clin Endocrinol Metab; 1978 Sep; 47(3):640-6. PubMed ID: 233678
[TBL] [Abstract][Full Text] [Related]
4. Hyperphosphatemic tumoral calcinosis: effects of phosphate depletion on vitamin D metabolism, and of acute hypocalcemia on parathyroid hormone secretion and action.
Lufkin EG; Kumar R; Heath H
J Clin Endocrinol Metab; 1983 Jun; 56(6):1319-22. PubMed ID: 6687726
[TBL] [Abstract][Full Text] [Related]
5. Phosphorus excretion in tumoral calcinosis: response to parathyroid hormone and acetazolamide.
Lufkin EG; Wilson DM; Smith LH; Bill NJ; DeLuca HF; Dousa TP; Knox FG
J Clin Endocrinol Metab; 1980 Apr; 50(4):648-53. PubMed ID: 7364922
[TBL] [Abstract][Full Text] [Related]
6. Effects of endogenous and exogenous parathyroid hormone on tubular reabsorption of calcium in pseudohypoparathyroidism.
Yamamoto M; Takuwa Y; Masuko S; Ogata E
J Clin Endocrinol Metab; 1988 Mar; 66(3):618-25. PubMed ID: 2832440
[TBL] [Abstract][Full Text] [Related]
7. Has vitamin D a direct renal effect on the tubular reabsorption of phosphate? A study in parathyroidectomized (PTX) and non-PTX man.
Madsen S; Olgaard K
Adv Exp Med Biol; 1978; 103():111-23. PubMed ID: 717102
[TBL] [Abstract][Full Text] [Related]
8. The renal response to exogenous parathyroid hormone in treated pseudohypoparathyroidism.
Stone MD; Hosking DJ; Garcia-Himmelstine C; White DA; Rosenblum D; Worth HG
Bone; 1993; 14(5):727-35. PubMed ID: 8268047
[TBL] [Abstract][Full Text] [Related]
9. Resistance to the phosphaturic and calcemic actions of parathyroid hormone during phosphate depletion. Prevention by 1,25-dihydroxyvitamin D3.
Gloor HJ; Bonjour JP; Caverzasio J; Fleisch H
J Clin Invest; 1979 Mar; 63(3):371-7. PubMed ID: 34630
[TBL] [Abstract][Full Text] [Related]
10. 1alpha(OH)D3 One-alpha-hydroxy-cholecalciferol--an active vitamin D analog. Clinical studies on prophylaxis and treatment of secondary hyperparathyroidism in uremic patients on chronic dialysis.
Brandi L
Dan Med Bull; 2008 Nov; 55(4):186-210. PubMed ID: 19232159
[TBL] [Abstract][Full Text] [Related]
11. Exaggerated phosphaturic response to circulating parathyroid hormone in patients with familial X-linked hypophosphatemic rickets.
Short E; Morris RC; Sebastian A; Spencer M
J Clin Invest; 1976 Jul; 58(1):152-63. PubMed ID: 180058
[TBL] [Abstract][Full Text] [Related]
12. Mechanism of resistance to the phosphaturic effect of the parathyroid hormone in the hamster.
Knox FG; Preiss J; Kim JK; Dousa TP
J Clin Invest; 1977 Apr; 59(4):675-83. PubMed ID: 14974
[TBL] [Abstract][Full Text] [Related]
13. Circulating parathyroid hormone activity: familial hypocalciuric hypercalcemia versus typical primary hyperparathyroidism.
Marx SJ; Spiegel AM; Brown EM; Windeck R; Gardner DG; Downs RW; Attie M; Aurbach GD
J Clin Endocrinol Metab; 1978 Dec; 47(6):1190-7. PubMed ID: 233692
[TBL] [Abstract][Full Text] [Related]
14. Inappropriate phosphate excretion in idiopathic hypercalciuria: the key to a common cause and future treatment?
Williams CP; Child DF; Hudson PR; Soysa LD; Davies GK; Davies MG; De Bolla AR
J Clin Pathol; 1996 Nov; 49(11):881-8. PubMed ID: 8944605
[TBL] [Abstract][Full Text] [Related]
15. Renal tubular effects of chronic phosphate depletion.
Goldfarb S; Westby GR; Goldberg M; Agus ZS
J Clin Invest; 1977 May; 59(5):770-79. PubMed ID: 856868
[TBL] [Abstract][Full Text] [Related]
16. Pathophysiology of calcium metabolism in children with vitamin D-deficiency rickets.
Kruse K
J Pediatr; 1995 May; 126(5 Pt 1):736-41. PubMed ID: 7751997
[TBL] [Abstract][Full Text] [Related]
17. [Clinical study of pseudohypoparathyroidism Type I & Type II (author's transl)].
Yamada K; Tamura Y; Yamamoto M; Kumagai A
Nihon Naibunpi Gakkai Zasshi; 1976 Oct; 52(10):983-96. PubMed ID: 190053
[TBL] [Abstract][Full Text] [Related]
18. Correlations of serum concentrations of 1,25-dihydroxyvitamin D, phosphorus, and parathyroid hormone in tumoral calcinosis.
Lyles KW; Halsey DL; Friedman NE; Lobaugh B
J Clin Endocrinol Metab; 1988 Jul; 67(1):88-92. PubMed ID: 3379139
[TBL] [Abstract][Full Text] [Related]
19. Normocalcemic primary hyperparathyroidism: resistance to PTH effect on tubular reabsorption of calcium.
Gardin JP; Paillard M
Miner Electrolyte Metab; 1984; 10(5):301-8. PubMed ID: 6493158
[TBL] [Abstract][Full Text] [Related]
20. The hypercalciurias. Causes, parathyroid functions, and diagnostic criteria.
Pak CY; Oata M; Lawrence EC; Snyder W
J Clin Invest; 1974 Aug; 54(2):387-400. PubMed ID: 4367891
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
